$HIPH - Just out PRESS RELEASE/ News! $HIPH closes JV deal

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
234
$HIPH - Just out PRESS RELEASE/ News! $HIPH closes JV deal with China based company to sell products in China &Asia markets. CEO states he wants to sell $HIPH 's hydrogen infused #CBD product in Asia
(see PR below)


PLAYA VISTA, CA / ACCESSWIRE / March 15, 2018 / American Premium Water Corporation (OTC PINK: HIPH) announces that its Gents subsidiary has entered into a joint venture with Zhangjiagang Advanced Company (ZAC) to market and sell Gents in China and other Asian markets.

American Premium Water Corporation (OTC PINK: HIPH) is pleased to announce that Gents has agreed to a joint venture with Zhangjigang to market and sell the Gents brand line of products throughout mainland China and other countries in eastern Asia. HIPH is also exploring partnerships for LALPINA Hydrogen CBD distribution in the region as well.

Ryan Fishoff, CEO American Premium Water Corporation stated, "This is a significant step for the brand to expand internationally. Working together with ZATC, we have a partner that will help us expand our footprint internationally and establish a presence in the world's largest market. It also establishes a base to setup distribution in other major markets in the area, including Japan and Korea."

Fred Su, Principal of ZAC spoke of the partnership "I am really excited, and looking forward to our new partnership with the Gents premium brand and introducing them to the Chinese market. The Chinese population loves premium American brands, and I think Gents has the potential to capture a large part of the market that continues to grow rapidly. We will have special collections created exclusively for the Asian markets which will further establish the brand in our country."

Mr. Fishoff is currently in China this week to execute the agreement and set the strategy for the launch. Gents will create an e-commerce site exclusively for the Chinese market and will also sell products on JD.com (JD). The tentative launch for the collaboration will be for Fathers Day, as its celebrated at the same time in both the US and China.

Mr. Fishoff added, "I am excited to go to China to personally see the initiation of this partnership and plot out our strategic plans for the rest of 2018. This is just the first piece of a broader international strategy for Gents and HIPH. This partnership will give us a foothold in Asia and allow us to pursue many opportunities across the continent. While I am in China, I will be also having conversations with regional beverage distributors who are interested in our Hydrogen CBD product."

HIPH has previously announced it has a created a hydrogen infused CBD beverage under the LALPINA Hydrogen CBD brand. The Company still anticipates the product will be available for sale by June or earlier. Cannabinoid, a natural phycannbinoid extracted from cannabis is just being introduced in Asian countries, including China, and these markets offer tremendous opportunity to grow by establishing a first to market in these countries.

Establishing a foothold in the continent will give HIPH a potential strategic advantage over other competitors in the CBD space who have focused on domestic markets like PotNetwork Holding Inc (POTN), Rocky Mountain HIgh Brands (RMHB), Isodiol (ISOLF) and Elev8 Brands Inc (VATE)

"Having a foothold in China will allow us to achieve all our strategic growth objectives. I hope our Gents joint venture will be the first of many different partnerships and ventures in China. Now that we are establishing a presence there, I will pursue licensing and JV opportunities with other brands, in line with our growth through acquisition growth initiatives. Also, working with International Monetary, they have a number of relationships in Asia, and I have seen how they were able to leverage them to grow NFusz (FUSZ) which I am confident they can replicate for us"

Please follow us on our social media outlets listed below:

@americanpremium

@lalpinabrands

@GentsCo

#Gentsco

#lalpinahydrogen

For more information on American Premium Water Corporation / HIPH, go to http://www.lalpinahydrogen.com/investor-page.html

Gents

The New York-based Gents is a producer of luxury hats and other fine accessories and apparel. Their line is carried in over 200 retail outlets internationally, including Bloomingdale’s (M), Nordstrom (JWN), and Saks Fifth Avenue (HBC).

Visit www.gentsco.com to learn more. https://www.gentsco.com

@GentsCo

#GentsCo

Safe Harbor Notice

Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC" EDGAR database.

This press release is issued on behalf of the Board of Directors by Alfred Culbreth, Founder /Director.

Disclaimer Regarding Forward Looking Statements

Certain statements in this press release, on American Premium Water Corporation's ("APWC" website and other oral and written statements made by APWC from time to time are "forward-looking statements", as that term is defined in Section 27A of the United States Securities and Exchange Act of 1933, as amended, and Section 21E of the United States Securities and Exchange Act of 1934, as amended, Forward-looking statements include, without limitation, statements regarding beliefs, objectives, intentions, goals, plans, strategies, financial projections, any other statements regarding the future and any statements that are not purely historical. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and APWC expressly disclaims any obligation to update or revise any forward-looking statements to reflect events or circumstances after the date thereof. All forward-looking statements, whether written or oral and whether made by or on behalf of the APWC, are expressly qualified by these cautionary statements. Forward-looking statements involve risks and uncertainties which could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. APWC’s expectations, beliefs and projections are expressed in good faith and are believed by the APWC to have a reasonable basis, but there can be no assurance that management's expectations, beliefs or projections will result or be achieved or accomplished. A variety of factors, many of which are beyond APWC's control affect APWC's operations, performance, business strategy and results and could cause the actual results, performance or achievements of APWC to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. For APWC, particular uncertainties arise, amongst others but not limited to and not in any order of importance, from (i) focusing on and allocating more resources on certain target markets (ii) the possibility to raise further equity and debt to fund future growth, (iii) changes in demand for APWC's products, (iv) performance issues with key suppliers, affiliates, agents, advisors or subcontractors, (v) changes in government changes in laws or regulations to which APWC or its suppliers are subject, including environmental laws and regulations relating to water or water sources and (vi) the inability to complete announced acquisitions, difficulty or unanticipated expenses in connection with integrating acquired businesses and the risk that anticipated synergies and opportunities as a result of acquisitions will not be realized or the risk that acquisitions do not perform as planned, including, for example, the risk that acquired businesses will not achieve revenue projections.

THIS NEWS RELEASE HAS BEEN PREPARED BY APWC’S MANAGEMENT, WHO TAKES FULL RESPONSIBILITY FOR ITS CONTENTS. NO SECURITIES REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED OF THE CONTENTS OF THIS NEWS RELEASE. THIS NEWS RELEASE SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.

Contact Information:

American Premium Water Corporation

12777 Jefferson Blvd.

Suite 300

Playa Vista, CA 90066-7408

(888)-983-0054

Stock Symbol: HIPH

General Inquiries: info@americanpremiumwater.com

Investor Relations: ir@americanpremiumwater.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 311

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 150

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 105

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 354

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 35

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

VIQ Solutions' Leadership Transition Marks New Era Ahead

Updated Category News Views 244

VIQ Solutions Marks a New Chapter with Leadership Changes VIQ Solutions Inc. is making noteworthy changes in its executive team that will undoubtedly shape the organization's path forward. The firm, known for being a global provider of AI-driven, secure digital voice and video capture technology, has announced the retirement of Susan Sumner, who has been a pivotal figure...

Continue Reading
Lucid Group's Fourth Quarter Success: Record Deliveries Ahead

Updated Category News Views 130

Lucid Group Inc Reports Strong Q4 Earnings Lucid Group Inc (NASDAQ: LCID) has revealed its fourth-quarter financial results, demonstrating a significant improvement in revenue and production metrics. The results were reported after the market closed on a recent Tuesday, showcasing the company's ongoing commitment to innovation in the electric vehicle sector. Revenue...

Continue Reading
Verily Sightline Collaborates with Bangor University in Europe

Updated Category News Views 149

Verily Partners with Bangor University for Wastewater Testing Verily, recognized for its precision health technology, is extending its wastewater surveillance program into Europe through a promising partnership with Bangor University. This collaboration aims to take advantage of the innovative wastewater-based public health programs at Bangor to enhance testing...

Continue Reading
Amaero's Strategic Supply Agreement Boosts U.S. Titanium Production

Updated Category News Views 213

Amaero Secures Strategic Long-Term Supply Agreement Significant Milestone in Domestic Supply Chain Development Amaero International Limited (ASX:3DA), a prominent U.S. manufacturer of high-quality titanium powders, has successfully signed a three-year Supply Agreement with The Perryman Company, a leader in titanium production. This agreement marks a pivotal moment in...

Continue Reading
NextPlat: Insights from Interim CEO on Future Directions

Updated Category News Views 132

NextPlat Corp's Interim CEO Update NextPlat Corp (NASDAQ: NXPL), a prominent player in the consumer products and services sector, recently issued a pivotal update from its interim CEO, David Phipps. This detailed letter serves as a roadmap to navigate the company’s future after the unexpected passing of its former CEO, Charles M. Fernandez. The focus is on leveraging...

Continue Reading